Quick Answer
Fulgent Genetics, Inc. reported Net Income of -$60.51 million for fiscal year 2025.
Fulgent Genetics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$60.51M | -41.7% |
| 2024 | -$42.71M | +74.6% |
| 2023 | -$167.82M | -217.0% |
| 2022 | $143.40M | -71.7% |
| 2021 | $507.36M | +136.7% |
| 2020 | $214.31M | +52243.6% |
| 2019 | -$411.0K | +92.7% |
| 2018 | -$5.61M | -123.4% |
| 2017 | -$2.51M | +53.1% |
| 2016 | -$5.35M | +35.7% |
| 2015 | -$8.31M | -94.1% |
| 2014 | -$4.28M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.61M | +54.9% | +65.1% |
| June 30, 2025 | -$18.96M | -117.6% | -64.4% |
| March 31, 2025 | -$11.53M | +14.4% | +21.3% |
| September 30, 2024 | -$14.65M | -11.8% | -68.2% |
| June 30, 2024 | -$8.71M | +22.4% | +35.3% |
| March 31, 2024 | -$13.46M | +12.2% | -2.7% |
| September 30, 2023 | -$13.11M | -862.5% | -16.7% |
| June 30, 2023 | -$11.23M | -197.3% | +26.8% |
- Fulgent Genetics, Inc. showed a decrease of -41.7% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Fulgent Genetics, Inc.’s net income has declined by 1312.9% (from -$4.28 million to -$60.51 million).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: